Viewing Study NCT00362050


Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2026-01-01 @ 7:20 AM
Study NCT ID: NCT00362050
Status: COMPLETED
Last Update Posted: 2007-08-29
First Post: 2006-08-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: RBx11160 Phase II Dose Ranging Study RBx/MMV05-06
Sponsor: Medicines for Malaria Venture
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module